Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT02874885
What this trial is testing

Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal AdenocarcinomaMetastatic Rectal AdenocarcinomaRectosigmoid Adenocarcinoma+10 more
M.D. Anderson Cancer Center 341
Large-scale testing (Phase 3)Ended earlyNCT00070122
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI) 2,200
Not applicableActive Not RecruitingNCT07565831
What this trial is testing

Study on the Prediction of Regional Lymph Node Metastasis in Colorectal Cancer by Spectral CT Combined With MSI

Who this might be right for
Colo-rectal Cancer
Yunnan Cancer Hospital 260
Large-scale testing (Phase 3)UnknownNCT00482222
What this trial is testing

Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University of Southampton 340
Testing effectiveness (Phase 2)Ended earlyNCT01609231
What this trial is testing

A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025)

Who this might be right for
Rectal Neoplasms
Merck Sharp & Dohme LLC 11
Testing effectiveness (Phase 2)Study completedNCT00630786
What this trial is testing

Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study

Who this might be right for
Colon CancerColorectal CancerRectal Cancer+2 more
Amgen 53
Testing effectiveness (Phase 2)Study completedNCT00003446
What this trial is testing

Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Grupo Oncologico Cooperativo del Sur
Testing effectiveness (Phase 2)Study completedNCT01269229
What this trial is testing

A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis

Who this might be right for
Rectal Cancer
Yonsei University 32
Large-scale testing (Phase 3)Active Not RecruitingNCT02997228
What this trial is testing

Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study

Who this might be right for
Metastatic Colorectal AdenocarcinomaStage IV Colorectal Cancer AJCC v7
National Cancer Institute (NCI) 120
Large-scale testing (Phase 3)Ended earlyNCT01279681
What this trial is testing

Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

Who this might be right for
Cognitive/Functional EffectsColorectal CancerNeurotoxicity
Alliance for Clinical Trials in Oncology 32
Testing effectiveness (Phase 2)Study completedNCT01289821
What this trial is testing

First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib

Who this might be right for
Colorectal Neoplasms
Bayer 54
Not applicableWithdrawnNCT04045236
What this trial is testing

AIMS Academy Clinical Research Network - Non Metastatic Rectal Cancer Operated on With Curative Intent

Who this might be right for
Non Metastatic Rectal Cancer
Niguarda Hospital
Early research (Phase 1)Study completedNCT00959127
What this trial is testing

ARRY-438162 (MEK162) in Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorsAdvanced or Metastatic Biliary CancerMetastatic Colorectal Cancer
Array Biopharma, now a wholly owned subsidiary of Pfizer 93
Large-scale testing (Phase 3)Study completedNCT00056459
What this trial is testing

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal NeoplasmsColonic NeoplasmsRectal Neoplasms
Novartis 1,168
Not applicableLooking for participantsNCT06536127
What this trial is testing

Prospective Monocentric Study Evaluating the Circulating NK Cells Phenotype and the ImmunoScore® in Patients With Non Metastatic Rectal Cancer

Who this might be right for
Rectal CancerNon Metastatic Cancer
Institut Sainte Catherine 100
Not applicableUnknownNCT03476122
What this trial is testing

Clinical Application of an Automated Liquid Biopsy Platform for Early Detection of Colorectal Cancer

Who this might be right for
Colo-rectal Cancer
CellMaxLife 750
Not applicableUnknownNCT03263663
What this trial is testing

Optimization of Individualized Therapy for CRCs With Secondary RESISTance Towards Anti-EGFR Targeted Therapy Using an Avatar Model

Who this might be right for
Colo-rectal CancerRAS Wild-typeUICC III+2 more
PD Dr. med. Volker Heinemann 1,000
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Large-scale testing (Phase 3)Ended earlyNCT00720512
What this trial is testing

Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab

Who this might be right for
Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 184
Early research (Phase 1)Study completedNCT00003543
What this trial is testing

Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center 18
Next Page